Umbilical cord dressings aim to heal stubborn diabetic foot sores
NCT ID NCT07449975
First seen Mar 19, 2026 · Last updated Jun 20, 2026 · Updated 17 times
Summary
This study tests whether two skin substitutes made from donated human umbilical cord tissue can help heal diabetic foot ulcers that won't close with standard care. About 272 adults with diabetes and a foot ulcer will receive either the cord-based dressing plus standard care or standard care alone for up to 12 weeks. The main goal is to see if more ulcers close completely with the added treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC FOOT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dehydrated human umbilical cord-based skin substitutes (Corplex P, Theracor)
What this could lead to
If successful, this could provide a new treatment option that helps heal stubborn diabetic foot ulcers faster, reducing infection risk and amputations.
What could go wrong
This is an early-stage trial with no phase, so results are uncertain. The devices may not heal ulcers better than standard care, and there are risks of infection or allergic reaction.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.